![](https://www.globalcompliancenews.com/wp-content/uploads/sites/43/2023/02/budapest.jpg)
Hungary: Pharmaceutical law developments
In brief Under the recently published Act XXIX of 2024 amending certain acts concerning the operation of the State, as of 1 January 2025, certain decisions on named patient reimbursement of medicinal products will be made by a newly created public benefit …